Compare BAFN & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BAFN | BDSX |
|---|---|---|
| Founded | 1999 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.9M | 122.0M |
| IPO Year | 2021 | 2020 |
| Metric | BAFN | BDSX |
|---|---|---|
| Price | $5.61 | $17.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.50 |
| AVG Volume (30 Days) | 10.0K | ★ 153.6K |
| Earning Date | 01-01-0001 | 05-21-2026 |
| Dividend Yield | ★ 1.36% | N/A |
| EPS Growth | ★ 133.93 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $88,499,000.00 |
| Revenue This Year | N/A | $23.35 |
| Revenue Next Year | N/A | $19.33 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 24.08 |
| 52 Week Low | $5.23 | $0.25 |
| 52 Week High | $19.00 | $20.21 |
| Indicator | BAFN | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 38.87 | 62.47 |
| Support Level | N/A | $6.33 |
| Resistance Level | $8.26 | N/A |
| Average True Range (ATR) | 0.43 | 1.84 |
| MACD | -0.09 | 0.20 |
| Stochastic Oscillator | 25.26 | 65.98 |
BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.